Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × naldemedine × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Opioid-Induced Constipation 3 Vomiting 1 Neoplasms 1 Nausea 1 Constipation 1

Interventions

naldemedine 1 Standard of Care 1 Octreotide 1 Fecal Microbiota Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Recruiting

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡